比较家庭健康行动支持(FAM-ACT)与传统社区健康工作者主导干预改善成人糖尿病管理与结局的有效性:随机对照试验研究方案
本研究为平行组随机对照试验,拟纳入268对由糖化血红蛋白升高的2型糖尿病FQHC患者及其支持者组成的二元组,随机接受FAM-ACT或I-DSMES干预6个月,主要结局为患者基线与6个月间HbA1c变化,并评估12个月HbA1c变化、血压、自我管理行为、糖尿病痛苦、患者激活、自我效能及支持者相关结局。
要点
- FAM-ACT为社区健康工作者主导、同时教育患者与支持者的新型干预。
- 对照为已建立的、以个体患者为中心的DSMES与护理管理干预。
- 主要结局为患者基线与6个月间HbA1c变化。
核心结论
- 本研究将评估FAM-ACT相对于I-DSMES改善2型糖尿病患者HbA1c及自我管理相关结局的有效性。
研究设计与样本
- 平行组随机对照试验,计划纳入268对由FQHC的2型糖尿病且HbA1c高的患者及其支持者组成的二元组。
- 研究在同一城市FQHC合作开展,服务低收入拉丁裔社区,两种干预均采用基于社区的参与性研究方法开发。
- 患者-支持者二元组随机接受FAM-ACT或I-DSMES干预,持续6个月。
主要发现
- 主要结局为患者HbA1c从基线至6个月的变化。
- 次要患者结局包括12个月HbA1c变化、血压变化、糖尿病自我管理行为、糖尿病痛苦、患者激活、糖尿病自我效能及对支持者支持的感知与满意度。
- 次要支持者结局包括帮助患者管理糖尿病的自我效能及支持者对患者糖尿病的痛苦。
- 研究还将评估COVID-19大流行对患者管理糖尿病能力的影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究方案针对并评估于低收入且以拉丁裔为主的社区,可能增加对其他类似社区的适用性。
- COVID-19大流行对研究方案和干预实施带来若干挑战,文中描述了为应对这些挑战所做的修改。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes self-management education and support (DSMES) programs have struggled to deliver sustainable, effective support for adults with diabetes (AWDs) to improve self-management behaviors, achieve glycemic goals, and reduce risk for complications. One largely untapped resource for this support is AWDs' social networks. Fifty to 75% of AWDs have an unpaid family member or friend ("support person") who provides ongoing help with diabetes management. However, DSMES interventions to date lack structured and effective approaches to directly engage support persons in AWDs' diabetes management. METHODS: This parallel arm randomized trial is designed to determine the effectiveness of Family Support for Health Action (FAM-ACT), a novel community health worker (CHW)-delivered program focused on educating and supporting patients with type 2 diabetes (T2D) and their support persons (SPs), relative to an established, CHW-delivered, individual patient-focused DSMES and care management (I-DSMES) intervention. Both interventions were developed using a community-based participatory research (CBPR) approach. The study will be conducted in partnership with an urban Federally Qualified Health Center (FQHC) serving a low-income, Latino/a community, with target enrollment of 268 dyads consisting of an FQHC patient with T2D with high HbA1c and an SP. Patient-SP dyads will be randomized to receive FAM-ACT or I-DSMES over 6 months. The primary outcome is change in patient HbA1c from baseline to 6 months. Secondary patient outcomes include 12-month change in HbA1c, changes in patient blood pressure, diabetes self-management behaviors, diabetes distress, patient activation, diabetes self-efficacy, and perceptions of and satisfaction with SP support for diabetes. Secondary SP outcomes include self-efficacy for helping the patient with diabetes management and SP distress about the patient's diabetes. We also will assess the effect of the COVID-19 pandemic on patient's ability to manage diabetes. DISCUSSION: This study will inform scalable, evidence-based approaches that leverage family support to help AWDs improve and sustain self-management strategies that underpin optimal management of multiple diabetes complication risk factors. The protocol is designed for and evaluated with a low-income and predominantly Latino/a community, which may increase applicability to other similar communities. The COVID-19 pandemic presented several challenges to study protocol and intervention delivery; modifications made to address these challenges are described. TRIAL REGISTRATION: ClinicalTrials.gov NCT03812614. Registered on 18 January 2019.
引用
- Deverts DJ, Heisler M, Kieffer EC, et al. Comparing the effectiveness of Family Support for Health Action (FAM-ACT) with traditional community health worker-led interventions to improve adult diabetes management and outcomes: study protocol for a randomized controlled trial. Trials. 2022. PMID: 36192769. doi:10.1186/s13063-022-06764-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。